Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

[1]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[2]  I. Pavord,et al.  Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. , 1999, The European respiratory journal.

[3]  A J Wardlaw,et al.  Eosinophilic bronchitis is an important cause of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[4]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[5]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[6]  H. Boushey.  Glucocorticoid therapy for chronic obstructive pulmonary disease. , 1999, The New England journal of medicine.

[7]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[8]  I. Pavord,et al.  The safety and success rate of sputum induction using a low output ultrasonic nebuliser. , 1999, Respiratory medicine.

[9]  P. Calverley.  Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease , 1999, Thorax.

[10]  F. Hargreave,et al.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. , 1998, American journal of respiratory and critical care medicine.

[11]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[12]  N. Hara,et al.  Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. , 1998, The European respiratory journal.

[13]  B. Beghé,et al.  Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease , 1998, Thorax.

[14]  N. Barnes.  Inhaled steroids in COPD , 1998, The Lancet.

[15]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[16]  J. Bousquet,et al.  Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.

[17]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[18]  A. Peacock,et al.  Making measurements in the pulmonary circulation: when and how? , 1997, Thorax.

[19]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[20]  L. Fabbri,et al.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. , 1996, Thorax.

[21]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[22]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[23]  M. S. Singh,et al.  Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.

[24]  A. Robertson,et al.  Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. , 1990, Thorax.

[25]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[26]  G. Mchardy,et al.  Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. , 1987, Thorax.

[27]  A. Janoff,et al.  Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. , 2015, The American review of respiratory disease.

[28]  M. H. Williams,et al.  Response to corticosteroids in chronic bronchitis. , 1978, The Journal of allergy and clinical immunology.

[29]  C. Stuart-harris,et al.  Steroid therapy in chronic bronchitis. , 1962, Lancet.